We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$484M
AUM Growth
+$36.9M
Cap. Flow
+$6.09M
Cap. Flow %
1.26%
Top 10 Hldgs %
26.56%
Holding
273
New
13
Increased
78
Reduced
63
Closed
4

Top Buys

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$973K
2
WY icon
Weyerhaeuser
WY
+$638K
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$453K
4
AIG icon
American International
AIG
+$430K
5
VNO icon
Vornado Realty Trust
VNO
+$423K

Top Sells

Rank Stock Value
1
NWSA
NEWS CORPORATION CL-A
NWSA
+$326K
2
SRPT icon
Sarepta Therapeutics
SRPT
+$272K
3
CP icon
Canadian Pacific Kansas City
CP
+$231K
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$224K
5
AMGN icon
Amgen
AMGN
+$169K

Sector Composition

Rank Sector Weight
1 Healthcare 22.9%
2 Industrials 12.46%
3 Consumer Staples 12.36%
4 Energy 9.49%
5 Technology 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMI icon
176
Kinder Morgan
KMI
$70.5B
$443K 0.09%
12,448
– –
APC
177
DELISTED
Anadarko Petroleum
APC
$442K 0.09%
4,750
-100
-2% -$9.1K
APU
178
DELISTED
AmeriGas Partners, L.P.
APU
$439K 0.09%
10,200
+1,250
+14% +$55.5K
ELV icon
179
Elevance Health
ELV
$81.6B
$431K 0.09%
5,153
– –
PNC icon
180
PNC Financial Services
PNC
$99.2B
$430K 0.09%
5,932
– –
SD
181
DELISTED
SANDRIDGE ENERGY, INC.
SD
$430K 0.09%
73,300
– –
PCYC
182
DELISTED
PHARMACYCLICS INC
PCYC
$429K 0.09%
3,100
– –
DHR icon
183
Danaher
DHR
$138B
$425K 0.09%
9,126
– –
CCL icon
184
Carnival Corporation Ltd
CCL
$38B
$424K 0.09%
13,000
– –
BCE icon
185
BCE
BCE
$20.2B
$421K 0.09%
9,850
+1,400
+17% +$58.2K
VNO icon
186
Vornado Realty Trust
VNO
$7.55B
$420K 0.09%
+6,834
New +$423K
DVN icon
187
Devon Energy
DVN
$50.9B
$413K 0.09%
7,150
-200
-3% -$11.4K
PARA
188
DELISTED
Paramount Global Class B
PARA
$408K 0.08%
7,403
– –
DD icon
189
DuPont de Nemours
DD
$18.7B
$406K 0.08%
4,176
– –
SOXX icon
190
iShares Semiconductor ETF
SOXX
$41.7B
$406K 0.08%
18,270
– –
WBA
191
DELISTED
Walgreens Boots Alliance
WBA
$403K 0.08%
7,493
– –
XLF icon
192
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$398K 0.08%
22,783
– –
EFA icon
193
iShares MSCI EAFE ETF
EFA
$78.5B
$393K 0.08%
6,164
+545
+10% +$33.4K
PHO icon
194
Invesco Water Resources ETF
PHO
$2B
$388K 0.08%
16,210
-200
-1% -$4.61K
HCA icon
195
HCA Healthcare
HCA
$85.7B
$385K 0.08%
9,000
– –
TEL icon
196
TE Connectivity
TEL
$59.9B
$380K 0.08%
7,331
– –
AMZN icon
197
Amazon
AMZN
$2.53T
$375K 0.08%
24,000
– –
VTV icon
198
Vanguard Morningstar Value ETF
VTV
$188B
$372K 0.08%
5,337
-349
-6% -$24.6K
WU icon
199
Western Union
WU
$2.4B
$372K 0.08%
19,920
– –
HSBC icon
200
HSBC
HSBC
$367B
$364K 0.08%
7,777
+580
+8% +$27.5K
6 7
8
9 10

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Gerald L. Ray & Associates held 273 positions worth $484M, up 8.3% from $447M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Gerald L. Ray & Associates's Q3 2013 filing shows 13 new, 78 increased, 63 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 46,550 shares worth $1.28M. The largest sale was NEWS CORPORATION CL-A, an estimated $326K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q3 2013 buy was Acadia Pharmaceuticals: 46,550 shares worth $1.28M.
  • Gerald L. Ray & Associates added most to American International in Q3 2013, an estimated $430K increase.
  • Gerald L. Ray & Associates's biggest Q3 2013 reduction was Regeneron Pharmaceuticals, cutting an estimated $224K.
  • Gerald L. Ray & Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $326K.
  • Gerald L. Ray & Associates's ten largest holdings make up 27% of its $484M portfolio in Q3 2013.
  • Gerald L. Ray & Associates opened 13 new positions and closed 4 in Q3 2013.
  • Gerald L. Ray & Associates's portfolio value rose 8.3% quarter-over-quarter to $484M.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2013, filed 5 Nov 2013.